Semaglutide is a GLP-1 receptor research peptide and the active compound behind the brands Ozempic and Wegovy. Here is what you need to know about it.
How semaglutide works
Semaglutide activates the GLP-1 receptor, which is involved in appetite regulation and glucose control. It is one of the most studied GLP-1 research peptides.
Research applications
Semaglutide is studied in metabolic and weight management research. As a research compound, it is not approved for human use and is supplied for laboratory protocols only.
Semaglutide research in Egypt
Researchers in Egypt looking for semaglutide-class materials can find GLP-1 research peptides in our catalogue, including tirzepatide and retatrutide. Every batch is third party lab tested with a published certificate.
Important
Ozempic and Wegovy are registered medicines. We do not sell them. We supply research peptides for laboratory and research use only, not for human or veterinary use.